BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6380516)

  • 1. Fever in the patient with cancer. Pathophysiology and the initial evaluation and management.
    Gutiérrez-Nuñez JJ
    Bol Asoc Med P R; 1984 Jun; 76(6):256-64. PubMed ID: 6380516
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 3. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
    Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH
    J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850
    [No Abstract]   [Full Text] [Related]  

  • 4. [Granulocytopenia in oncohematology].
    Mandelli F; Avvisati G; Fenu S; Venditti M; Martino P
    Ann Ist Super Sanita; 1987; 23(4):727-30. PubMed ID: 3452282
    [No Abstract]   [Full Text] [Related]  

  • 5. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.
    Pizzo PA; Robichaud KJ; Gill FA; Witebsky FG
    Am J Med; 1982 Jan; 72(1):101-11. PubMed ID: 7058815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the febrile neutropenic patient.
    Mandell LA
    Can Med Assoc J; 1983 Apr; 128(8):915-7. PubMed ID: 6831337
    [No Abstract]   [Full Text] [Related]  

  • 8. [Episodes of fever in the agranulocytic phase of the treatment of acute myeloblastic leukemia in adults].
    Bernard JF; Renoux M; Boivin P
    Sem Hop; 1976 Jan; 52(2):111-3. PubMed ID: 185700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.
    Levine AS; Schimpff SC; Graw RG; Young RC
    Semin Hematol; 1974 Apr; 11(2):141-202. PubMed ID: 4212049
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and management of perianal and perirectal infection in the granulocytopenic patient.
    Rolston KV; Bodey GP
    Curr Clin Top Infect Dis; 1993; 13():164-71. PubMed ID: 8397908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and treatment of infection in the support of the neutropenic patient].
    Rafecas FJ; Sanz MA; Martín-Aragones G; Martínez JA; Sayas MJ; Marty ML
    Sangre (Barc); 1985; 30(4-B):501-14. PubMed ID: 4081964
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutropenia and fever.
    Hughes WT
    Pediatr Infect Dis; 1983; 2(3 Suppl):S14-7. PubMed ID: 6866796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infections in neutropenic patients].
    Berenguer J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
    [No Abstract]   [Full Text] [Related]  

  • 14. Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
    Menichetti F; Bucaneve G; Patoia L; Guerciolini R; Minotti V; Pauluzzi S; Del Favero A
    Chemioterapia; 1987 Jun; 6(2 Suppl):403-5. PubMed ID: 3334584
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention, diagnosis and therapy of infections in patients with malignant diseases].
    Hiddemann W; Maschmeyer G; Runde V; Einsele H
    Internist (Berl); 1996 Dec; 37(12):1212-24. PubMed ID: 9081922
    [No Abstract]   [Full Text] [Related]  

  • 16. Empiric antibiotic therapy.
    Schimpff SC; Aisner J
    Cancer Treat Rep; 1978 May; 62(5):673-80. PubMed ID: 350396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in the epidemiology of infection in the granulocytopenic patient (author's transl)].
    Garau Alemany J
    Sangre (Barc); 1979; 24(5B):836-44. PubMed ID: 524230
    [No Abstract]   [Full Text] [Related]  

  • 18. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
    Cordonnier C; Leverger G; Schlemmer B; Andremont A; Boasson M; Herbrecht R; Kazmierczak A; Marie JP; Marit G; Miclea JM
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):289-91. PubMed ID: 7971247
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of fever in granulocytopenic children with cancer.
    Katz JA; Mustafa MM
    Pediatr Infect Dis J; 1993 Apr; 12(4):330-7. PubMed ID: 8483628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.